Transcutaneous vagus nerve stimulation (t-VNS) in pharmacoresistant epilepsies: a proof of concept trial

Epilepsia
Hermann StefanRüdiger Hopfengärtner

Abstract

To elucidate, in a pilot-study, whether noninvasive transcutaneous vagus nerve stimulation (t-VNS) is a safe and tolerable alternative treatment option in pharmacoresistant epilepsy. t-VNS was applied to 10 patients with pharmacoresistant epilepsies. Stimulation via the auricular branch of the vagus nerve of the left tragus was delivered three times per day for 9 months. Subjective documentation of stimulation effects was obtained from patients' seizure diaries. For a more reliable assessment of seizure frequency, we carried out prolonged outpatient video-electroencephalography (EEG) monitoring. In addition, computerized testing of cognitive, affective, and emotional functions was performed. Three patients aborted the study. Of the remaining seven patients, an overall reduction of seizure frequency was observed in five patients after 9 months of t-VNS. The noninvasive t-VNS stimulation is a safe and well-tolerated method for relatively long periods, and might be an alternative treatment option for patients with epilepsy.

Associated Clinical Trials

Sep 24, 2019·Theodoros Zanos

References

Oct 27, 1979·British Medical Journal·S D Shorvon, E H Reynolds
Feb 5, 2000·The New England Journal of Medicine·P Kwan, M J Brodie
Aug 4, 2001·The New England Journal of Medicine·S WiebeUNKNOWN Effectiveness and Efficiency of Surgery for Temporal Lobe Epilepsy Study Group
Sep 25, 2007·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·R HopfengärtnerH Stefan
Mar 20, 2009·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·H Stefan, R Hopfengärtner
Dec 3, 2010·Seizure : the Journal of the British Epilepsy Association·H StefanR Hopfengärtner

❮ Previous
Next ❯

Citations

Mar 26, 2013·Der Nervenarzt·A Schulze-Bonhage, V Coenen
Nov 3, 2012·Epilepsy Currents·Elinor Ben-Menachem
Jan 28, 2014·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Rüdiger HopfengärtnerHajo Hamer
May 17, 2014·Current Behavioral Neuroscience Reports·Robert H Howland
Apr 9, 2014·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Leen De TaeyeRobrecht Raedt
Mar 8, 2014·Anatomical Science International·Juri KiyokawaKeiichi Akita
Jun 7, 2013·Continuum : Lifelong Learning in Neurology·Christopher M DeGiorgio, Scott E Krahl
May 1, 2015·Neurologia Medico-chirurgica·Takamichi Yamamoto
Nov 29, 2015·Neurosurgery Clinics of North America·Vibhor KrishnaRichard Wennberg
Jan 31, 2013·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·B BonazD Clarençon
Sep 15, 2015·Headache·Hsiangkuo Yuan, Stephen D Silberstein
Sep 19, 2015·Headache·Hsiangkuo Yuan, Stephen D Silberstein
Mar 10, 2015·Journal of the American College of Cardiology·Stavros StavrakisSunny S Po
Mar 31, 2016·Neuroscience and Biobehavioral Reviews·D C W KloosterP Boon
Jul 27, 2015·European Archives of Psychiatry and Clinical Neuroscience·Alkomiet HasanThomas Wobrock
Jan 24, 2015·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·E Ben-MenachemS Silberstein
May 27, 2014·Neuroscience and Biobehavioral Reviews·Kristl VonckPaul Boon
Dec 31, 2014·Evidence-based Complementary and Alternative Medicine : ECAM·Shuping ChenJianliang Zhang
Apr 19, 2016·The Journal of Clinical Investigation·Tsuyoshi InoueMark D Okusa
Mar 16, 2013·Epilepsy Research·Udaya SeneviratneWendyl D'Souza
Mar 26, 2015·Neurobiology of Aging·Heidi I L JacobsAlexander T Sack
Aug 29, 2014·Brain Stimulation·Jennifer A ClancyJim Deuchars
Sep 28, 2014·Lancet·Solomon L MoshéTorbjörn Tomson
Jul 11, 2014·Frontiers in Neurology·Peter Y CaiVishnumurthy Shushrutha Hedna
Jun 28, 2016·The Anatomical Record : Advances in Integrative Anatomy and Evolutionary Biology·Sami SafiWinfried Neuhuber
Jul 8, 2016·Expert Review of Neurotherapeutics·Markus Gschwind, Margitta Seeck
Jun 28, 2014·BMC Complementary and Alternative Medicine·Feng HuangPeijing Rong
Nov 17, 2016·Journal of Neural Transmission·Camelia-Lucia CimpianuAlkomiet Hasan
Jul 24, 2014·Arquivos de neuro-psiquiatria·Pedro ShiozawaFelipe Fregni
Oct 27, 2017·Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society·Iñigo Garamendi-Ruiz, Juan Carlos Gómez-Esteban
Nov 9, 2018·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·Gun-Soo HongSven Wehner

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.